Adient (ADNT) Up 3.8% Since Last Earnings Report: Can It Continue?
Adient (ADNT) reported earnings 30 days ago. What's next for the stock?
ADNT - Adient plc
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$28.00
DETAILS
HIGH:
$34.00
LOW:
$21.00
MEDIAN:
$28.00
CONSENSUS:
$28.00
UPSIDE:
39.93%
Stock News
New Strong Sell Stocks for August 24th
AGCO, ADNT and AEM have been added to the Zacks Rank #5 (Strong Sell) List on August 24th, 2026.
Adient Eyes 2027 Margin Growth as Onshoring Wins and Automation Build Momentum
Adient NYSE: ADNT executives said the automotive seating supplier expects to finish fiscal 2026 in line with commitments and enter fiscal 2027 with continued revenue growth, improving business performance and margin expansion, supported by Americas onshoring wins, China growth and automation investments.
Adient's Ana Romero-Davila is recognized as a Rising Star
PLYMOUTH, Mich., Aug. 17, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that Ana Romero-Davila, platform director at the company, has been named a 2026 Automotive News Rising Star.
Adient plc (ADNT) Presents at J.P. Morgan Automotive Conference Transcript
Adient plc (ADNT) Presents at J.P. Morgan Automotive Conference Transcript
Assenagon Asset Management S.A. Sells 357,321 Shares of Adient $ADNT
Assenagon Asset Management S.A. reduced its stake in shares of Adient (NYSE: ADNT) by 63.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,832 shares of the company's stock after selling 357,321 shares during the quarter.
Adient Q3 Earnings Miss Estimates on Higher Commodity Expenses
ADNT's Q3 earnings miss estimates despite a sales beat, as higher commodity and freight costs and Middle East disruptions pressure margins.
Adient Q3 Earnings Call Highlights
Adient NYSE: ADNT reported third-quarter fiscal 2026 revenue of approximately $3.9 billion, up 5% from a year earlier, while adjusted EBITDA was flat at $225 million as conflict-related commodity and freight costs, customer production disruptions and operating inefficiencies weighed on profitability.
Adient plc (ADNT) Q3 2026 Earnings Call Transcript
Adient plc (ADNT) Q3 2026 Earnings Call Transcript
Adient (ADNT) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Adient (ADNT) Misses Q3 Earnings Estimates
Adient (ADNT) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.45 per share a year ago.
Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26
PLYMOUTH, Mich., Aug. 5, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its third quarter 2026 financial results.
Adient (ADNT) Projected to Release Quarterly Earnings on Wednesday
Adient (NYSE: ADNT - Get Free Report) is expected to be issuing its Q3 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $0.5630 per share and revenue of $3.7086 billion for the quarter. Investors are encouraged to explore the company's upcoming Q3 2026 earning summary page
Adient PLC (ADNT) Shares Fall 3.8% -- What GF Score of 72 Tells Investors
On July 31, 2026, Adient PLC (ADNT) shares fell 3.8% to a current price of $21.04. This decline comes amid a 52-week range of $17.68 to $27.32, reflecting a cha
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Adient (ADNT) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Adient (ADNT) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Adient to discuss Q3 fiscal 2026 financial results on August 5, 2026
PLYMOUTH, Mich., July 14, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, will host a conference call on August 5, 2026, at 8:30 a.m.
Will Adient (ADNT) Beat Estimates Again in Its Next Earnings Report?
Adient (ADNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Adient (ADNT) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Price Targets
Adient price target lowered to $21 from $22 at Morgan Stanley
$21.00
(was $20.01)
Morgan Stanley
Adient price target lowered to $28 from $29 at Deutsche Bank
$28.00
(was $19.57)
Edison Yu
·
Deutsche Bank
Adient price target raised to $34 from $33 at UBS
$34.00
(was $19.30)
Joseph Spak
·
UBS
Adient price target lowered to $29 from $31 at Deutsche Bank
$29.00
(was $19.29)
Deutsche Bank
Adient price target raised to $29 from $26 at Barclays
$29.00
(was $22.78)
Barclays
Adient price target raised to $31 from $30 at Deutsche Bank
$31.00
(was $22.35)
Deutsche Bank
Adient price target raised to $33 from $32 at UBS
$33.00
(was $22.32)
UBS
Adient price target raised to $28 from $26 at Stifel
$28.00
(was $22.32)
Nathan Jones
·
Stifel Nicolaus
Adient price target raised to $22 from $20 at Morgan Stanley
$22.00
(was $24.26)
Morgan Stanley
Adient price target raised to $32 from $30 at UBS
$32.00
(was $24.26)
UBS
Adient price target raised to $26 from $24 at Stifel
$26.00
(was $21.79)
Stifel Nicolaus
Adient price target raised to $25 from $24 at Barclays
$25.00
(was $21.85)
Barclays
Adient upgraded to Buy from Neutral at UBS
$30.00
(was $21.45)
UBS
Adient price target raised to $29 from $28 at Wells Fargo
$29.00
(was $20.60)
Colin Langan
·
Wells Fargo
Adient price target raised to $29 from $27 at Stifel
$29.00
(was $22.82)
Stifel Nicolaus
Adient price target raised to $27 from $25 at Barclays
$27.00
(was $23.39)
Barclays
Adient price target raised to $28 from $26 at UBS
$28.00
(was $25.89)
UBS
Adient upgraded to Overweight from Equal Weight at Wells Fargo
$31.00
(was $24.71)
Wells Fargo
Adient price target lowered to $17 from $19 at Morgan Stanley
$17.00
(was $14.74)
Morgan Stanley
Adient upgraded to Neutral from Underperform at Exane BNP Paribas
$26.00
(was $24.71)
James Picariello
·
BNP Paribas